How long should you take SS-31 (Forzinity)?
•
4 min read
Following the FDA's accelerated approval in September 2025, elamipretide, now known as Forzinity, is the first approved treatment for Barth syndrome. Clinical trial data indicates that treatment duration for this chronic condition extends well beyond the initial study period, with some patients safely receiving the medication for several years.
